(-0.01%) 5 307.59 points
(0.04%) 39 925 points
(-0.07%) 16 730 points
(0.74%) $79.21
(3.10%) $2.49
(-0.38%) $2 385.70
(0.56%) $29.90
(-0.07%) $1 069.30
(0.16%) $0.920
(0.29%) $10.70
(0.10%) $0.789
(0.16%) $90.83
Live Chart Being Loaded With Signals
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices...
Stats | |
---|---|
Today's Volume | 3.73M |
Average Volume | 5.70M |
Market Cap | 182.39B |
EPS | $0 ( 2024-04-17 ) |
Next earnings date | ( $1.100 ) 2024-07-18 |
Last Dividend | $0.550 ( 2024-04-12 ) |
Next Dividend | $0 ( N/A ) |
P/E | 32.66 |
ATR14 | $0.0390 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-10 | Funck, Jr. Robert E. | Buy | 10 097 | Common shares without par value |
2024-05-10 | Funck, Jr. Robert E. | Sell | 10 097 | Common shares without par value |
2024-05-10 | Funck, Jr. Robert E. | Sell | 10 097 | Option (right to buy) |
2024-05-07 | Earnhardt Lisa D | Sell | 22 852 | Common shares without par value |
2024-04-26 | Stratton John G | Buy | 1 866 | Common shares without par value |
INSIDER POWER |
---|
50.74 |
Last 99 transactions |
Buy: 1 148 349 | Sell: 428 762 |
Volume Correlation
Abbott Laboratories Correlation
10 Most Positive Correlations | |
---|---|
ULE | 0.948 |
FXE | 0.947 |
UDN | 0.941 |
EWN | 0.937 |
BWX | 0.936 |
DRI | 0.935 |
NERD | 0.934 |
LEMB | 0.932 |
EMLC | 0.932 |
BYM | 0.931 |
10 Most Negative Correlations | |
---|---|
EUO | -0.946 |
UUP | -0.923 |
TNK | -0.916 |
USDU | -0.909 |
DEX | -0.902 |
TYO | -0.893 |
PST | -0.892 |
TBX | -0.886 |
TMV | -0.883 |
MIE | -0.883 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Abbott Laboratories Correlation - Currency/Commodity
Abbott Laboratories Financials
Annual | 2023 |
Revenue: | $40.11B |
Gross Profit: | $22.13B (55.18 %) |
EPS: | $3.30 |
FY | 2023 |
Revenue: | $40.11B |
Gross Profit: | $22.13B (55.18 %) |
EPS: | $3.30 |
FY | 2022 |
Revenue: | $43.65B |
Gross Profit: | $24.51B (56.15 %) |
EPS: | $3.94 |
FY | 2021 |
Revenue: | $43.08B |
Gross Profit: | $24.54B (56.97 %) |
EPS: | $3.99 |
Financial Reports:
No articles found.
Abbott Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.470 (N/A) |
$0.470 (N/A) |
$0.510 (N/A) |
$0.510 (N/A) |
$0.510 (N/A) |
$0.510 (N/A) |
$0.550 (N/A) |
$0.550 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00589 | 1983-01-11 |
Last Dividend | $0.550 | 2024-04-12 |
Next Dividend | $0 | N/A |
Payout Date | 2024-05-15 | |
Next Payout Date | N/A | |
# dividends | 166 | -- |
Total Paid Out | $25.20 | -- |
Avg. Dividend % Per Year | 1.43% | -- |
Score | 6.06 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.03 | |
Div. Directional Score | 9.96 | -- |
Year | Amount | Yield |
---|---|---|
1983 | $0.0269 | 2.59% |
1984 | $0.0323 | 2.50% |
1985 | $0.0379 | 3.32% |
1986 | $0.0452 | 2.37% |
1987 | $0.0398 | 1.49% |
1988 | $0.0644 | 2.36% |
1989 | $0.0756 | 2.82% |
1990 | $0.0904 | 2.32% |
1991 | $0.108 | 2.22% |
1992 | $0.129 | 1.71% |
1993 | $0.148 | 2.17% |
1994 | $0.166 | 2.57% |
1995 | $0.184 | 2.50% |
1996 | $0.209 | 2.23% |
1997 | $0.296 | 2.62% |
1998 | $0.263 | 1.73% |
1999 | $0.296 | 1.35% |
2000 | $0.332 | 2.11% |
2001 | $0.368 | 1.70% |
2002 | $0.409 | 1.63% |
2003 | $0.435 | 2.42% |
2004 | $0.477 | 2.27% |
2005 | $0.521 | 2.33% |
2006 | $0.558 | 2.94% |
2007 | $0.610 | 2.60% |
2008 | $0.675 | 2.52% |
2009 | $0.749 | 2.91% |
2010 | $0.825 | 3.16% |
2011 | $0.901 | 3.93% |
2012 | $0.965 | 3.55% |
2013 | $0.560 | 1.75% |
2014 | $0.880 | 2.30% |
2015 | $0.960 | 2.14% |
2016 | $1.040 | 2.42% |
2017 | $1.060 | 2.71% |
2018 | $1.120 | 1.91% |
2019 | $1.280 | 1.84% |
2020 | $1.440 | 1.66% |
2021 | $1.800 | 1.65% |
2022 | $1.880 | 1.35% |
2023 | $2.04 | 1.86% |
2024 | $1.100 | 1.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend King | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
SCM | Dividend Royal | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.140 | 1.500 | 7.21 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0777 | 1.200 | 7.41 | 8.89 | [0 - 0.3] |
returnOnEquityTTM | 0.148 | 1.500 | 9.47 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.644 | -1.000 | 3.56 | -3.56 | [0 - 1] |
currentRatioTTM | 1.596 | 0.800 | 7.02 | 5.62 | [1 - 3] |
quickRatioTTM | 0.945 | 0.800 | 9.14 | 7.32 | [0.8 - 2.5] |
cashRatioTTM | 0.448 | 1.500 | 8.62 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.201 | -1.500 | 6.65 | -9.97 | [0 - 0.6] |
interestCoverageTTM | 10.86 | 1.000 | 7.09 | 7.09 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.12 | 2.00 | 8.63 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.84 | 2.00 | 8.58 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.376 | -1.500 | 8.50 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.541 | 1.000 | 4.31 | 4.31 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.167 | 1.000 | 8.65 | 8.65 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.490 | 1.000 | 8.39 | 8.39 | [0.2 - 2] |
assetTurnoverTTM | 0.556 | 0.800 | 9.62 | 7.70 | [0.5 - 2] |
Total Score | 12.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.21 | 1.000 | 6.85 | 0 | [1 - 100] |
returnOnEquityTTM | 0.148 | 2.50 | 9.66 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.84 | 2.00 | 9.05 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.03 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.12 | 2.00 | 8.63 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.644 | 1.500 | 3.56 | -3.56 | [0 - 1] |
pegRatioTTM | 4.92 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.177 | 1.000 | 8.07 | 0 | [0.1 - 0.5] |
Total Score | 7.03 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators